GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Market Cap

BioDelivery Sciences International (FRA:BD5) Market Cap : €523.2 Mil (As of May. 28, 2024)


View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BioDelivery Sciences International's share price for the quarter that ended in Dec. 2021 was €2.72. BioDelivery Sciences International's Shares Outstanding (EOP) for the quarter that ended in Dec. 2021 was 101.5 Mil. Therefore, BioDelivery Sciences International's market cap for the quarter that ended in Dec. 2021 was €276.2 Mil.

BioDelivery Sciences International's quarterly market cap increased from Jun. 2021 (€299.5 Mil) to Sep. 2021 (€308.2 Mil) but then declined from Sep. 2021 (€308.2 Mil) to Dec. 2021 (€276.2 Mil).

BioDelivery Sciences International's annual market cap declined from Dec. 2019 (€572.2 Mil) to Dec. 2020 (€334.5 Mil) and declined from Dec. 2020 (€334.5 Mil) to Dec. 2021 (€276.2 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BioDelivery Sciences International's Enterprise Value for Today is €472.9 Mil.


BioDelivery Sciences International Market Cap Historical Data

The historical data trend for BioDelivery Sciences International's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Market Cap Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 130.78 178.36 572.23 334.47 276.18

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 334.47 326.20 299.53 308.23 276.18

Competitive Comparison of BioDelivery Sciences International's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioDelivery Sciences International's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Market Cap distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's Market Cap falls into.



BioDelivery Sciences International Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

BioDelivery Sciences International's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as

Market Cap (A: Dec. 2021 )=Share Price (A: Dec. 2021 )*Shares Outstanding (EOP) (A: Dec. 2021 )
=€2.72*101.536
=€276.2

BioDelivery Sciences International's Market Cap for the quarter that ended in Dec. 2021 is calculated as

Market Cap (Q: Dec. 2021 )=Share Price (Q: Dec. 2021 )*Shares Outstanding (EOP) (Q: Dec. 2021 )
=€2.72*101.536
=€276.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioDelivery Sciences International  (FRA:BD5) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


BioDelivery Sciences International Market Cap Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


BioDelivery Sciences International (FRA:BD5) Business Description

Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines